ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

QuantHealth has raised $45 million in a Series B funding [...]

Boehringer Ingelheim’s Jascayd has received European marketing authorisation for idiopathic [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]

Medicus Pharma has received authorisation from the UAE Department of [...]

The first UK patient has been dosed with a personalised [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

The US Food and Drug Administration (FDA) has approved Meitheal [...]

Verdiva Bio has dosed the first patient in a Phase [...]